Skip to content
ساردوتانت

Structure via PubChem · Public domain (PubChem)

EntityQ3473757· pop 6· linked from 36 articles

ساردوتانت

Sign in to save

Also known as SR 48,968, SR 48968, SR-48,968, SR48968, Saredutant

Saredutant (SR-48,968) is a drug that acts as a NK2 receptor antagonist. It was under development by Sanofi-Aventis as a novel antidepressant and anxiolytic and made it to phase III clinical trials. However, in May 2009, Sanofi-Aventis published its quarterly results and announced the cessation of 14 research/development projects, among which was saredutant for the treatment of major depressive disorder.

Chemical data

Formula
C31H35Cl2N3O2
Molecular weight
552.5 g/mol
IUPAC name
N-[(2S)-4-(4-acetamido-4-phenylpiperidin-1-yl)-2-(3,4-dichlorophenyl)butyl]-N-methylbenzamide
SMILES
CC(=O)NC1(CCN(CC1)CC[C@H](CN(C)C(=O)C2=CC=CC=C2)C3=CC(=C(C=C3)Cl)Cl)C4=CC=CC=C4
InChIKey
PGKXDIMONUAMFR-AREMUKBSSA-N
XLogP
5.9
Polar surface area
52.7 Ų
H-bond donors
1
H-bond acceptors
3
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Phase 3
Molecule type
Small molecule
Indications
anxiety, major depressive disorder, depressive disorder

via ChEMBL · EBI

Wikidata facts

Mass
551.210633
Show 3 more facts
chemical formula
C₃₁H₃₅Cl₂N₃O₂
isomeric SMILES
CC(=O)NC1(CCN(CC1)CC[C@H](CN(C)C(=O)C2=CC=CC=C2)C3=CC(=C(C=C3)Cl)Cl)C4=CC=CC=C4
canonical SMILES
CC(=O)NC1(CCN(CC1)CCC(CN(C)C(=O)C2=CC=CC=C2)C3=CC(=C(C=C3)Cl)Cl)C4=CC=CC=C4
Sources (2)

via Wikidata · CC0

Available in 6 languages

via Wikidata sitelinks · CC0